Healthcare - Biotechnology - NASDAQ - US
$ 1.18
-5.6 %
$ 63.8 M
Market Cap
3.47
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
21.35%
EBIT
Estimate
--68.60%
Net Income
Estimate
11.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Spero Therapeutics, Inc.
SPRO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SPRO
EBIT FORECAST
EBIT Forecast Chart SPRO
NET INCOME FORECAST
Net Income Chart SPRO